•
Jun 30, 2024

DaVita Q2 2024 Earnings Report

DaVita reported a positive quarter, enhancing clinical capabilities and optimizing revenue operations and cost structure.

Key Takeaways

DaVita Inc. announced financial results for Q2 2024, with consolidated revenues of $3.187 billion and operating income of $506 million. Diluted earnings per share were $2.50, and adjusted diluted earnings per share were $2.59. The company repurchased 2.7 million shares of its common stock at an average price of $140.14 per share.

Consolidated revenues reached $3.187 billion.

Operating income totaled $506 million.

Diluted earnings per share (EPS) stood at $2.50, with adjusted diluted EPS at $2.59.

Operating cash flow was $799 million, and free cash flow was $654 million.

Total Revenue
$3.19B
Previous year: $3B
+6.2%
EPS
$2.59
Previous year: $2.08
+24.5%
US Dialysis Treatments
7.27M
Previous year: 7.23M
+0.5%
US Avg Treatments per day
93.15K
Previous year: 92.71K
+0.5%
US Revenue per Treatment
$390
Previous year: $377
+3.6%
Gross Profit
$869M
Previous year: $945M
-8.0%
Cash and Equivalents
$416M
Previous year: $327M
+27.2%
Free Cash Flow
$654M
Previous year: $260M
+151.5%
Total Assets
$17B
Previous year: $17B
+0.4%

DaVita

DaVita

DaVita Revenue by Segment

DaVita Revenue by Geographic Location

Forward Guidance

DaVita provided adjusted operating income guidance between $1.910 billion and $2.010 billion, adjusted diluted net income per share attributable to DaVita Inc. between $9.25 and $10.05, and free cash flow between $950 million and $1.200 billion.

Positive Outlook

  • Adjusted operating income is expected to be between $1.910 billion and $2.010 billion.
  • Adjusted diluted net income per share attributable to DaVita Inc. is projected to be between $9.25 and $10.05.
  • Free cash flow is anticipated to range from $950 million to $1.200 billion.

Revenue & Expenses

Visualization of income flow from segment revenue to net income